The management of structural heart disease has seen remarkable progress with the rise of transcatheter and minimally invasive solutions. This session at WCC 2026 will focus on cutting-edge technologies such as TAVI, Mitra Clip, left atrial appendage occlusion, and tricuspid valve interventions. Attendees will explore patient selection criteria, imaging-guided procedures, heart team collaboration, and complication management. Real-world case reviews and future directions in valve repair and replacement will be discussed.